Importantly, nanoparticles conditioned with anti-TNFR2 could cause a markedly higher number of apoptotic cells in the tumor (81% and 65%) as compared with that induced by the treatment with ISO-PLGA-ADR (Fig. 6C and D; P < 0.001). The gene discussed is TNFRSF1B; the disease is neoplasm.